大细胞SHP2缺乏通过抑制MAPK/NF-κB-依赖性炎症来缓解糖尿病病
Xue Han1,2,3, Jiajia Wei1, Ruyi Zheng1
1Zhejiang Provincial Key Laboratory of Laboratory Animals and Safety Research, Hangzhou Medical College, Hangzhou, China.
Diabetes
|February 23, 2024
概括
巨细胞Src同质性2-含有蛋白质氨酸酸酶2 (SHP2) 加快糖尿病病 (DN). 抑制巨细胞中的SHP2为治疗DN提供了潜在的治疗策略,减少功能障碍和纤维化.
科学领域:
- 免疫学 免疫学 免疫学
- 分子生物学分子生物学
- 腎臟病學 (nephrology) 是一種醫學.
背景情况:
- 糖尿病病 (DN) 是糖尿病的一个主要并发症,主要是由慢性炎症驱动的.
- 确定关键的炎症点对于开发有效的DN治疗至关重要.
研究的目的:
- 在DN的背景下,研究Src同类2含蛋白氨酸酸酶2 (SHP2) 在巨细胞中的作用.
- 探索SHP2作为DN的潜在治疗点.
主要方法:
- 使用巨细胞特异性SHP2-knockout (SHP2-MKO) 小鼠和SHP2fl/fl小鼠接受了 estreptozotocin (STZ) 治疗.
- 在初级小鼠腹膜巨细胞 (MPM) 上进行RNA测序,以分析信号通路.
- 在糖尿病小鼠模型中使用药理学SHP2抑制剂SHP099.
主要成果:
- 在糖尿病患者和小鼠的巨细胞中,SHP2酸化被上调.
- SHP2-MKO小鼠在STZ诱导的糖尿病中表现出减弱的功能障碍,纤维化和炎症.
- 删除SHP2影响了MPM中的MAPK和NF-κB信号通路和细胞因子释放.
- 在1型和2型糖尿病小鼠中,SHP099治疗保护了脏.
结论:
- 巨细胞SHP2在糖尿病病变的发病过程中起到加速作用.
- 准SHP2,特别是在巨细胞中,为DN管理提供了一个有希望的治疗途径.
相关概念视频
The JAK-STAT Signaling Pathway
8.9K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
8.9K
MAPK Signaling Cascades
5.5K
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
5.5K


